Grace Therapeutics, Inc. (GRCE)
Net Income Growth
-369.66%
Quarterly · Period ending:
GRCE Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-369.66%period ending
Latest reported-369.66%period ending
GRCE Quarterly Net Income YoY % (-100.07% → -369.66%)
Year-over-year change
High-resolution chart · PNG
GRCE net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -369.6609% | |
| -230.0604% | |
| 46.8395% | |
| 61.8807% | |
| 6.0654% | |
| 121.0817% | |
| -88.5385% | |
| 22.5701% | |
| 32.8441% | |
| 89.0794% | |
| 39.3494% | |
| 10.0752% | |
| 8.5057% | |
| -706.5098% | |
| -8.5239% | |
| -496.5381% | |
| -22.1406% | |
| 45.2548% | |
| 8.285% | |
| 111.4231% | |
| 44.4343% | |
| -136.5948% | |
| 56.6942% | |
| 48.5701% | |
| 2.9757% | |
| 285.8701% | |
| -258.1756% | |
| -20.2708% | |
| -56.7748% | |
| -117.4538% | |
| 29.9852% | |
| -384.2105% | |
| -164.1614% | |
| -170.961% | |
| -104.2085% | |
| 11.6709% | |
| -8.864% | |
| -89.8993% | |
| -211.1951% | |
| 27.5795% | |
| -162.33% | |
| 72.5577% | |
| -162.163% | |
| 0.4031% | |
| 172.3906% | |
| -11.143% | |
| 165.5647% | |
| -8.1264% | |
| -123.9396% | |
| -74.0615% | |
| -24.6671% | |
| -1.0968% | |
| 24.117% | |
| -0.2089% | |
| -45.9939% | |
| -72.7064% | |
| -252.8125% | |
| -164.323% | |
| -103.8128% | |
| -151.9358% | |
| -60.3682% | |
| -55.0233% | |
| -85.5657% | |
| -100.0667% |